2025-09-08 |
13D/A |
MLYS / Mineralys Therapeutics, Inc. |
Samsara BioCapital, L.P. |
6,346,194 |
8.20 |
10.63 |
2025-09-08 |
13D/A |
MLYS / Mineralys Therapeutics, Inc. |
Ra Capital Management, L.p. |
7,796,433 |
9.90 |
24.00 |
2025-09-05 |
13D/A |
GPRE / Green Plains Inc. |
Ancora Alternatives LLC |
3,956,125 |
5.90 |
-32.31 |
2025-09-05 |
13D/A |
TCRT / Alaunos Therapeutics, Inc. |
Pmgc Capital Llc |
0 |
0.00 |
-100.00 |
2025-09-05 |
13D/A |
VALN / Valneva SE - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
21,810,176 |
11.60 |
54.53 |
2025-09-05 |
13D/A |
INDV / Indivior PLC |
Two Seas Capital LP |
10,329,152 |
8.30 |
-11.43 |
2025-09-04 |
13D/A |
NBY / NovaBay Pharmaceuticals, Inc. |
Poplar Point Capital Management Llc |
1,020,300 |
17.52 |
0.00 |
2025-09-04 |
13D/A |
PRQR / ProQR Therapeutics N.V. |
Van Herk Investments B.v. |
13,274,690 |
12.60 |
8.79 |
2025-09-03 |
13D/A |
COTY / Coty Inc. |
Cottage Holdco B.V. |
488,051,545 |
54.50 |
0.01 |
2025-09-03 |
13D/A |
VTVT / vTv Therapeutics Inc. |
Samsara BioCapital, L.P. |
343,223 |
9.90 |
29.22 |
2025-09-02 |
13D |
STTK / Shattuck Labs, Inc. |
Orbimed Advisors Llc |
6,306,127 |
9.99 |
|
2025-09-02 |
13D/A |
CARM / Carisma Therapeutics, Inc. |
HealthCap VII, L.P. |
0 |
0.00 |
-100.00 |
2025-09-02 |
13D/A |
SNTI / Senti Biosciences, Inc. |
Celadon Partners SPV 24 |
13,404,441 |
45.00 |
37.10 |
2025-08-29 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
36,884,567 |
29.10 |
-5.36 |
2025-08-29 |
13D/A |
CARM / Carisma Therapeutics, Inc. |
HealthCap VII, L.P. |
2,014,372 |
4.80 |
-25.99 |
2025-08-28 |
13D/A |
ORMP / Oramed Pharmaceuticals Inc. |
Kidron Nadav |
3,116,729 |
7.60 |
32.97 |
2025-08-26 |
13D/A |
STOK / Stoke Therapeutics, Inc. |
Blue Horizon Enterprise Ltd |
2,256,181 |
4.10 |
-30.71 |
2025-08-26 |
13D/A |
STTK / Shattuck Labs, Inc. |
Redmile Group, LLC |
6,379,095 |
9.90 |
12.85 |
2025-08-26 |
13D/A |
IVVD / Invivyd, Inc. |
M28 Capital Management LP |
9,548,250 |
4.60 |
3.24 |
2025-08-26 |
13D |
NBY / NovaBay Pharmaceuticals, Inc. |
Lazar David E. |
1,200,048 |
19.99 |
|
2025-08-22 |
13D/A |
ARVN / Arvinas, Inc. |
Logos Global Management LP |
6,300,000 |
8.60 |
31.25 |
2025-08-22 |
13D |
HYEX / Healthy Extracts Inc. |
Swanson Donald William |
13,075,920 |
77.50 |
|
2025-08-22 |
13D/A |
ANIP / ANI Pharmaceuticals, Inc. |
Meridian Venture Partners II GP, L.P. |
1,034,570 |
4.80 |
-12.66 |
2025-08-21 |
13D/A |
CARM / Carisma Therapeutics, Inc. |
HealthCap VII, L.P. |
2,721,923 |
6.50 |
-19.90 |
2025-08-21 |
13D/A |
KROS / Keros Therapeutics, Inc. |
ADAR1 Capital Management, LLC |
5,389,264 |
13.27 |
-0.03 |
2025-08-20 |
13D/A |
NAMS / NewAmsterdam Pharma Company N.V. |
Frazier Life Sciences X, L.P. |
7,327,937 |
6.50 |
-55.36 |
2025-08-20 |
13D/A |
KALV / KalVista Pharmaceuticals, Inc. |
Frazier Life Sciences Public Fund, L.P. |
2,400,276 |
4.80 |
-50.89 |
2025-08-20 |
13D/A |
ARQT / Arcutis Biotherapeutics, Inc. |
Frazier Life Sciences VIII, L.P. |
8,943,712 |
7.50 |
0.92 |
2025-08-20 |
13D/A |
PHAT / Phathom Pharmaceuticals, Inc. |
Frazier Life Sciences Public Fund, L.P. |
5,985,327 |
8.60 |
-58.52 |
2025-08-20 |
13D/A |
MIRM / Mirum Pharmaceuticals, Inc. |
Frazier Life Sciences IX, L.P. |
3,735,220 |
7.60 |
-40.01 |
2025-08-20 |
13D/A |
PRQR / ProQR Therapeutics N.V. |
Van Herk Investments B.v. |
12,202,190 |
11.60 |
6.09 |
2025-08-19 |
13D/A |
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) |
New Enterprise Associates 14, L.P. |
4 |
0.00 |
-100.00 |
2025-08-19 |
13D/A |
IOBT / IO Biotech, Inc. |
Novo Holdings A/S |
4,981,588 |
7.30 |
-14.46 |
2025-08-18 |
13D/A |
OSTX / OS Therapies Incorporated |
Auerbach Shalom |
2,677,570 |
8.50 |
-0.37 |
2025-08-18 |
13D/A |
CMPX / Compass Therapeutics, Inc. |
Commander Aggregator, LP |
7,788,150 |
4.50 |
|
2025-08-18 |
13D/A |
MRKR / Marker Therapeutics, Inc. |
New Enterprise Associates 16, L.P. |
1,625,678 |
12.60 |
0.00 |
2025-08-15 |
13D/A |
BHC / Bausch Health Companies Inc. |
Icahn Partners Master Fund LP |
0 |
0.00 |
-100.00 |
2025-08-15 |
13D/A |
CMPX / Compass Therapeutics, Inc. |
Orbimed Advisors Llc |
15,219,994 |
8.90 |
0.00 |
2025-08-15 |
13D/A |
ARWR / Arrowhead Pharmaceuticals, Inc. |
Sarepta Therapeutics, Inc. |
0 |
0.00 |
-100.00 |
2025-08-15 |
13D/A |
IRON / Disc Medicine, Inc. |
Atlas Venture Fund X, L.P. |
1,084,527 |
3.10 |
-22.65 |
2025-08-14 |
13D/A |
BHC / Bausch Health Companies Inc. |
Paulson & Co. Inc. |
70,755,869 |
19.10 |
115.77 |
2025-08-14 |
13D/A |
ACLX / Arcellx, Inc. |
New Enterprise Associates 15, L.P. |
3,055,360 |
5.51 |
-18.42 |
2025-08-14 |
13D/A |
BBIO / BridgeBio Pharma, Inc. |
Viking Global Investors Lp |
18,602,920 |
9.70 |
0.00 |
2025-08-14 |
13D/A |
SLDB / Solid Biosciences Inc. |
Ra Capital Management, L.p. |
7,997,510 |
9.90 |
|
2025-08-14 |
13D/A |
ORIC / ORIC Pharmaceuticals, Inc. |
Sr One Capital Management, Llc |
4,615,384 |
4.75 |
0.00 |
2025-08-13 |
13D/A |
AUPH / Aurinia Pharmaceuticals Inc. |
ILJIN SNT Co., Ltd. |
6,535,141 |
5.00 |
-13.33 |
2025-08-13 |
13D/A |
AVBP / ArriVent BioPharma, Inc. |
Orbimed Advisors Llc |
3,027,328 |
7.50 |
0.00 |
2025-08-13 |
13D |
CVAC / CureVac N.V. |
Glaxosmithkline Plc |
16,591,937 |
74.00 |
0.00 |
2025-08-13 |
13D |
PCSA / Processa Pharmaceuticals, Inc. |
HX Entertainment Ltd |
5,467,181 |
10.90 |
|
2025-08-12 |
13D/A |
ARMP / Armata Pharmaceuticals, Inc. |
Innoviva, Inc. |
55,467,459 |
83.30 |
-13.57 |